Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells

Molecular and Cellular Biology

Volumn 33, Issue 19, 2013, Pages 3749-3761

  Ivanov, Konstantin I ^a,b   Agalarov, Yan ^a   Valmu, Leena ^c   Samuilova, Olga ^a   Liebl, Johanna ^d   Houhou, Nawal ^e   Hajjami, Hélène Maby El ^a   Norrmén, Camilla ^b   Jaquet, Muriel ^a   Miura, Naoyuki ^f   Zangger, Nadine ^e   Ylä Herttuala, Seppo ^g   Delorenzi, Mauro ^e,i,j   Petrova, Tatiana V ^a,b,h  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF MUNICH   (Germany)

^e SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h EPFL   (Switzerland)

ⁱ Ludwig Center for Cancer Research   (Switzerland)

^j UNIVERSITY OF LAUSANNE   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROLINE; SERINE; THREONINE; TRANSCRIPTION FACTOR FOXC2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; LYMPH VESSEL ENDOTHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOTHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HEK293 CELLS; HEP G2 CELLS; HUMANS; IMMUNOBLOTTING; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROLINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE; THREONINE; TRANSCRIPTION, GENETIC;

EID: 84886769145     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01387-12     Document Type: Article

References (34)

1. Wijchers PJ, Burbach JP, Smidt MP. 2006. In control of biology: of mice, men, and Foxes. Biochem. J. 397:233-246.
2. Iida K, Koseki H, Kakinuma H, Kato N, Mizutani-Koseki Y, Ohuchi H, Yoshioka H, Noji S, Kawamura K, Kataoka Y, Ueno F, Taniguchi M, Yoshida N, Sugiyama T, Miura N. 1997. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124:4627-4638.
3. Winnier GE, Kume T, Deng K, Rogers R, Bundy J, Raines C, Walter MA, Hogan BL, Conway SJ. 1999. Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles. Dev. Biol. 213:418-431.
4. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. 2000. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema- distichiasis syndrome. Am. J. Hum. Genet. 67:1382-1388.
5. Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Yla-Herttuala S, Miura N, Alitalo K. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10:974-981.
6. Dagenais SL, Hartsough RL, Erickson RP, Witte MH, Butler MG, Glover TW. 2004. Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Gene Expr. Patterns 4:611-619.
7. Kriederman BM, Myloyde TL, Witte MH, Dagenais SL, Witte CL, Rennels M, Bernas MJ, Lynch MT, Erickson RP, Caulder MS, Miura N, Jackson D, Brooks BP, Glover TW. 2003. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum. Mol. Genet. 12:1179-1185.
8. Norrmén C, Ivanov KI, Cheng J, Zangger N, Delorenzi M, Jaquet M, Miura N, Puolakkainen P, Horsley V, Hu J, Augustin HG, Yla-Herttuala S, Alitalo K, Petrova TV. 2009. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell Biol. 185:439-457.
9. Brice G, Mansour S, Bell R, Collin JR, Child AH, Brady AF, Sarfarazi M, Burnand KG, Jeffery S, Mortimer P, Murday VA. 2002. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J. Med. Genet. 39:478-483.
10. Mellor RH, Brice G, Stanton AW, French J, Smith A, Jeffery S, Levick JR, Burnand KG, Mortimer PS. 2007. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 115:1912-1920.
11. Gardner KH, Montminy M. 2005. Can you hear me now? Regulating transcriptional activators by phosphorylation. Sci. STKE 2005:pe44.
12. Yang JY, Hung MC. 2009. A new fork for clinical application: targeting forkhead transcription factors in cancer. Clin. Cancer Res. 15:752-757.
13. Berry FB, Tamimi Y, Carle MV, Lehmann OJ, Walter MA. 2005. The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis. Hum. Mol. Genet. 14: 2619-2627.
14. Mäkinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, Wise L, Mercer A, Kowalski H, Kerjaschki D, Stacker SA, Achen MG, Alitalo K. 2001. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20:4762-4773.
15. Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, Stingl G, Kerjaschki D, Maurer D. 2001. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194:797-808.
16. Norrmén C, Vandevelde W, Ny A, Saharinen P, Gentile M, Haraldsen G, Puolakkainen P, Lukanidin E, Dewerchin M, Alitalo K, Petrova TV. 2010. Liprin (beta)1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity. Blood 115:906-909.
17. Laitinen M, Makinen K, Manninen H, Matsi P, Kossila M, Agrawal RS, Pakkanen T, Luoma JS, Viita H, Hartikainen J, Alhava E, Laakso M, Yla-Herttuala S. 1998. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum. Gene Ther. 9:1481-1486.
18. Tammela T, Saaristo A, Lohela M, Morisada T, Tornberg J, Norrmen C, Oike Y, Pajusola K, Thurston G, Suda T, Yla-Herttuala S, Alitalo K. 2005. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105:4642-4648.
19. Furumoto TA, Miura N, Akasaka T, Mizutani-Koseki Y, Sudo H, Fukuda K, Maekawa M, Yuasa S, Fu Y, Moriya H, Taniguchi M, Imai K, Dahl E, Balling R, Pavlova M, Gossler A, Koseki H. 1999. Notochorddependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development. Dev. Biol. 210:15-29.
20. Sarao R, Dumont DJ. 1998. Conditional transgene expression in endothelial cells. Transgenic Res. 7:421-427.
21. Zudaire E, Gambardella L, Kurcz C, Vermeren S. 2011. A computational tool for quantitative analysis of vascular networks. PLoS One 6:e27385. doi:10.1371/journal.pone.0027385.
22. Pitulescu ME, Schmidt I, Benedito R, Adams RH. 2010. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat. Protoc. 5:1518-1534.
23. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9:671-675.
24. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3.
25. Ji X, Li W, Song J, Wei L, Liu XS. 2006. CEAS: cis-regulatory element annotation system. Nucleic Acids Res. 34:W551-W554.
26. Goecks J, Nekrutenko A, Taylor J. 2010. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 11:R86.
27. Mäkinen KM, Ivanov KI. 2008. Phosphorylation analysis of plant viral proteins. Methods Mol. Biol. 451:339-359.
28. Lu KP, Zhou XZ. 2007. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signaling and disease. Nat. Rev. Mol. Cell. Biol. 8:904-916.
29. Berry FB, Mirzayans F, Walter MA. 2006. Regulation of FOXC1 stability and transcriptional activity by an epidermal growth factor-activated mitogen-activated protein kinase signaling cascade. J. Biol. Chem. 281: 10098-10104.
30. Hawkins RD, Ren B. 2006. Genome-wide location analysis: insights on transcriptional regulation. Hum. Mol. Genet. 15 Spec. No. 1: R1-R7.
31. Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M. 2008. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell 31:438-448.
32. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. 2008. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 105:10762-10767.
33. Danciu TE, Chupreta S, Cruz O, Fox JE, Whitman M, Iniguez-Lluhi JA. 2012. Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2. J. Biol. Chem. 287:18318-18329.
34. Fujita H, Kang M, Eren M, Gleaves LA, Vaughan DE, Kume T. 2006. Foxc2 is a common mediator of insulin and transforming growth factor beta signaling to regulate plasminogen activator inhibitor type I gene expression. Circ. Res. 98:626-634.